Skip to main content

Table 2 ESAS-FS values at Baseline and Follow up

From: Characterization of patients with brain metastases referred to palliative care

 

Brain Metastases (n = 90)

No Brain Metastases (n = 90)

p-value*

ESAS-FS: Baseline (median) [q1-q3]

   

 Pain

4 [2.3–6.8]

6 [3.3–8]

< 0.01

 Fatigue

5.5 [4–8]

6 [4–8]

0.56

 Nausea

1 [0–4]

1 [0–5]

0.76

 Depression

1 [0–4]

2 [0–4]

0.38

 Anxiety

2 [0–5.8]

2 [0–5.8]

0.70

 Drowsiness

3 [0–5]

3.5 [0–6]

0.46

 Shortness of Breath

1 [0–5]

2 [0–4.8]

0.43

 Appetite

5 [2–8]

5 [2–7]

0.93

 Wellbeing

5 [3–7]

5 [3–7]

0.68

 Sleep

5 [2–7]

5 [2–7]

0.80

 Financial

1 [0–5]

0 [0–3]

0.06

 Spiritual

0 [0–0]

0 [0–1]

0.37

 Total Symptom Score

37 [25–49]

40 [28–52]

0.31

ESAS-FS: Follow up (median) [q1-q3]

   

 Pain

4 [0.25–6.8]

5 [2–7]

0.10

 Fatigue

5.5 [3–8]

6 [4–7.8]

0.95

 Nausea

0 [0–3.8]

1.5 [0–3]

0.57

 Depression

1 [0–3]

1 [0–4]

0.83

 Anxiety

2 [0–5]

2 [0–4]

0.68

 Drowsiness

3 [1–3]

2.5 [0–5]

0.31

 Shortness of Breath

1 [0–4]

1 [0–5]

0.21

 Appetite

5 [2.3–7]

4 [2–6]

0.51

 Wellbeing

4 [2–5.8]

5 [3–7]

0.02

 Sleep

4 [1.3–6]

5 [3–7]

0.01

 Financial

1 [0–3]

1 [0–4]

0.57

 Spiritual

0 [0–1]

0 [0–1]

0.96

 Total Symptom Score

32 [23–46]

37 [26–46]

0.22

  1. *- Fisher’s exact test